Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case report

Abstract Background Pregabalin is a medication used to treat epilepsy, neuropathic pain and generalised anxiety disorder. The most common side effects of pregabalin include dizziness, drowsiness, weight gain, ataxia and diplopia. On the other hand, neutropenia and rash are rare side effects of prega...

Full description

Bibliographic Details
Main Authors: Sanjeev Sahota, Robin Geoffrey Parry, Giorgio Gentile
Format: Article
Language:English
Published: BMC 2019-06-01
Series:BMC Nephrology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12882-019-1401-3
_version_ 1828886677156790272
author Sanjeev Sahota
Robin Geoffrey Parry
Giorgio Gentile
author_facet Sanjeev Sahota
Robin Geoffrey Parry
Giorgio Gentile
author_sort Sanjeev Sahota
collection DOAJ
description Abstract Background Pregabalin is a medication used to treat epilepsy, neuropathic pain and generalised anxiety disorder. The most common side effects of pregabalin include dizziness, drowsiness, weight gain, ataxia and diplopia. On the other hand, neutropenia and rash are rare side effects of pregabalin, and at the time of writing, there are only two documented cases of neutropenia and one of rash in the literature, none of which involved renal transplant recipients. Case presentation We present a 37-year-old renal transplant recipient who was admitted with lethargy, sore throat, urticarial rash and neutropenia after recently being commenced on pregabalin. On physical examination, he had erythematous urticarial rash near his renal transplant scar, on his right elbow, left knee and left wrist. Bacterial/viral serology and immunology were all negative. A blood film confirmed neutropenia and revealed reactive lymphocytes and neutrophil left shift, and those features were compatible with drug reaction. After cessation of the pregabalin, the neutropenia resolved. No other causes of neutropenia or urticarial rash were identified. Conclusion To the best of our knowledge, we have described the first case of concomitant pregabalin-induced neutropenia and urticarial rash in a kidney transplant patient. This case report highlights the importance of close monitoring when starting any new medications, particularly in the immunosuppressed population, and is relevant because of the growing usage of pregabalin for treating neuropathic pain in such patients and the risk that a missed pregabalin-related neutropenia could lead to unnecessary modifications of the immunosuppressive treatment.
first_indexed 2024-12-13T11:49:01Z
format Article
id doaj.art-ec847635d8ca4384993596ca00ae18d1
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-12-13T11:49:01Z
publishDate 2019-06-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-ec847635d8ca4384993596ca00ae18d12022-12-21T23:47:25ZengBMCBMC Nephrology1471-23692019-06-012011410.1186/s12882-019-1401-3Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case reportSanjeev Sahota0Robin Geoffrey Parry1Giorgio Gentile2Department of Nephrology, Royal Cornwall Hospitals NHS TrustDepartment of Nephrology, Royal Cornwall Hospitals NHS TrustDepartment of Nephrology, Royal Cornwall Hospitals NHS TrustAbstract Background Pregabalin is a medication used to treat epilepsy, neuropathic pain and generalised anxiety disorder. The most common side effects of pregabalin include dizziness, drowsiness, weight gain, ataxia and diplopia. On the other hand, neutropenia and rash are rare side effects of pregabalin, and at the time of writing, there are only two documented cases of neutropenia and one of rash in the literature, none of which involved renal transplant recipients. Case presentation We present a 37-year-old renal transplant recipient who was admitted with lethargy, sore throat, urticarial rash and neutropenia after recently being commenced on pregabalin. On physical examination, he had erythematous urticarial rash near his renal transplant scar, on his right elbow, left knee and left wrist. Bacterial/viral serology and immunology were all negative. A blood film confirmed neutropenia and revealed reactive lymphocytes and neutrophil left shift, and those features were compatible with drug reaction. After cessation of the pregabalin, the neutropenia resolved. No other causes of neutropenia or urticarial rash were identified. Conclusion To the best of our knowledge, we have described the first case of concomitant pregabalin-induced neutropenia and urticarial rash in a kidney transplant patient. This case report highlights the importance of close monitoring when starting any new medications, particularly in the immunosuppressed population, and is relevant because of the growing usage of pregabalin for treating neuropathic pain in such patients and the risk that a missed pregabalin-related neutropenia could lead to unnecessary modifications of the immunosuppressive treatment.http://link.springer.com/article/10.1186/s12882-019-1401-3PregabalinNeutropeniaRashDrug reactionRenal transplant
spellingShingle Sanjeev Sahota
Robin Geoffrey Parry
Giorgio Gentile
Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case report
BMC Nephrology
Pregabalin
Neutropenia
Rash
Drug reaction
Renal transplant
title Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case report
title_full Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case report
title_fullStr Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case report
title_full_unstemmed Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case report
title_short Pregabalin-induced urticarial rash and neutropenia in a renal transplant recipient: a case report
title_sort pregabalin induced urticarial rash and neutropenia in a renal transplant recipient a case report
topic Pregabalin
Neutropenia
Rash
Drug reaction
Renal transplant
url http://link.springer.com/article/10.1186/s12882-019-1401-3
work_keys_str_mv AT sanjeevsahota pregabalininducedurticarialrashandneutropeniainarenaltransplantrecipientacasereport
AT robingeoffreyparry pregabalininducedurticarialrashandneutropeniainarenaltransplantrecipientacasereport
AT giorgiogentile pregabalininducedurticarialrashandneutropeniainarenaltransplantrecipientacasereport